Literature DB >> 8820401

The molecular basis for inherited bullous diseases.

B P Korge1, T Krieg.   

Abstract

In the past 5 years enormous progress have been made in our understanding of the molecular basis for a number of inherited skin diseases characterized by easy blistering of the skin and the mucous membranes after minor physical trauma. This increased fragility of the skin or its appendages is due to molecular defects in genes coding for different intra- and extracellular structural proteins which are responsible for mechanical strength at their sites of expression. These diseases encompass the group of epidermolysis bullosa and disorders of cornification such as bullous forms of ichthyosis, palmoplantar keratoderma, and pachyonychia congenita. On the basis of clinical, morphological, and ultrastructural observations the epidermolysis bullosa group has been divided into three major categories. In epidermolysis bullosa simplex blister formation appears within the basal cell layer of the epidermis, and many mutations have been found in the genes of keratin 5 and 14 which are both expressed in basal keratinocytes. Epidermolytic hyperkeratosis leads to an epidermal separation in the suprabasal cell layers. In these patients numerous point mutations have now been described in the suprabasally expressed genes of keratin 1 and 10. In ichthyosis bullosa of Siemens blisters occur in the more upper suprabasal epidermis coincidental with the expression of keratin 2e, and mutations have been detected in the corresponding gene. In epidermolytic palmoplantar hyperkeratosis the suprabasal epidermal splitting is restricted to palms and soles of the patient. In keratin 9, which reveals such an exclusive expression pattern, molecular defects have indeed been recognized. Most recently in two different clinical subtypes of pachyonychia congenita, which is characterized by defective nails and focal palmoplantar hyperkeratosis, point mutations have been found in the genes coding for keratins 6, 16, and 17. In junctional epidermolysis bullosa the separation takes place within the dermal-epidermal basement membrane at the level of the lamina lucida, and mutations have been found in three genes coding for different laminin chains, in the beta4 gene of alpha6beta4 integrin, and in the gene of collagen XVII. In dystrophic epidermolysis bullosa the tissue separation occurs beneath the basement membrane within the papillary dermis at the level of the anchoring fibrils, and several mutations have been identified in the collagen VII gene. The rapid unraveling of molecular defects in these disabling or even lethal inherited skin diseases makes possible a more precise and earlier prenatal diagnosis, creates new options for suitable therapeutic regimens, and even offers the hope of curing these diseases by means of somatic cell gene therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820401     DOI: 10.1007/bf00196781

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  121 in total

1.  Linkage of the epidermolytic hyperkeratosis phenotype and the region of the type II keratin gene cluster on chromosome 12.

Authors:  J M Bonifas; J W Bare; M A Chen; M K Lee; C A Slater; L A Goldsmith; E H Epstein
Journal:  J Invest Dermatol       Date:  1992-11       Impact factor: 8.551

2.  Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation.

Authors:  C Collin; R Moll; S Kubicka; J P Ouhayoun; W W Franke
Journal:  Exp Cell Res       Date:  1992-09       Impact factor: 3.905

3.  A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.

Authors:  S Kivirikko; J A McGrath; C Baudoin; D Aberdam; S Ciatti; M G Dunnill; J R McMillan; R A Eady; J P Ortonne; G Meneguzzi
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

4.  Identification of a homozygous exon-skipping mutation in the LAMC2 gene in a patient with Herlitz's junctional epidermolysis bullosa.

Authors:  J Vailly; L Pulkkinen; A M Christiano; K Tryggvason; J Uitto; J P Ortonne; G Meneguzzi
Journal:  J Invest Dermatol       Date:  1995-03       Impact factor: 8.551

5.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

6.  Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression.

Authors:  L Langbein; H W Heid; I Moll; W W Franke
Journal:  Differentiation       Date:  1993-12       Impact factor: 3.880

7.  Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease.

Authors:  N Domloge-Hultsch; W R Gammon; R A Briggaman; S G Gil; W G Carter; K B Yancey
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK).

Authors:  A Reis; H C Hennies; L Langbein; M Digweed; D Mischke; M Drechsler; E Schröck; B Royer-Pokora; W W Franke; K Sperling
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

9.  A gene for pachyonychia congenita is closely linked to the keratin gene cluster on 17q12-q21.

Authors:  C S Munro; S Carter; S Bryce; M Hall; J L Rees; L Kunkeler; A Stephenson; T Strachan
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

10.  Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis.

Authors:  J M Bonifas; K Matsumura; M A Chen; J Berth-Jones; P E Hutchison; M Zloczower; P O Fritsch; E H Epstein
Journal:  J Invest Dermatol       Date:  1994-10       Impact factor: 8.551

View more
  7 in total

Review 1.  Gene therapy for skin diseases.

Authors:  Emily Gorell; Ngon Nguyen; Alfred Lane; Zurab Siprashvili
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

2.  The combined effects of Map3k1 mutation and dioxin on differentiation of keratinocytes derived from mouse embryonic stem cells.

Authors:  Jingjing Wang; Bo Xiao; Eiki Kimura; Maureen Mongan; Ying Xia
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

3.  Nonsense mutations in AAGAB cause punctate palmoplantar keratoderma type Buschke-Fischer-Brauer.

Authors:  Kathrin A Giehl; Gertrud N Eckstein; Sandra M Pasternack; Silke Praetzel-Wunder; Thomas Ruzicka; Peter Lichtner; Kerstin Seidl; Mike Rogers; Elisabeth Graf; Lutz Langbein; Markus Braun-Falco; Regina C Betz; Tim M Strom
Journal:  Am J Hum Genet       Date:  2012-09-20       Impact factor: 11.025

4.  Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue.

Authors:  Zurab Siprashvili; Ngon T Nguyen; Maria Y Bezchinsky; M Peter Marinkovich; Alfred T Lane; Paul A Khavari
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

5.  The functional diversity of epidermal keratins revealed by the partial rescue of the keratin 14 null phenotype by keratin 16.

Authors:  R D Paladini; P A Coulombe
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

6.  In vitro assembly and structure of trichocyte keratin intermediate filaments: a novel role for stabilization by disulfide bonding.

Authors:  H Wang; D A Parry; L N Jones; W W Idler; L N Marekov; P M Steinert
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

7.  Directed expression of keratin 16 to the progenitor basal cells of transgenic mouse skin delays skin maturation.

Authors:  R D Paladini; P A Coulombe
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.